Analysis on the different effects of Lactobacillus paracasei in relieving constipation induced by loperamide in mice

  • YANG Shurong ,
  • ZHU Huiyue ,
  • WU Xiaobing ,
  • SUN Shanshan ,
  • SI Qian ,
  • ZHANG Qiuxiang ,
  • WANG Linlin ,
  • WANG Gang ,
  • ZHAO Jianxin ,
  • ZHANG Hao ,
  • CHEN Wei
Expand
  • (School of Food Science and Technology, Jiangnan University, Wuxi 214122, China)

Received date: 2019-07-21

  Online published: 2020-03-13

Abstract

In this study, the effects of four strains of Lactobacillus paracasei LC2, LC3, LC38, and FJSWX33-L2 on constipation relief were evaluated, and the possible pathways of their differential effects were analyzed. Thirty-six Balb/c male mice were randomly divided into 6 groups. The normal group and the model group were intragastrically administered with 3% sucrose solution and the other groups were administered with L. paracasei for 14 days (109 CFU/ (d·each)). From the 15th day to the 30th day, except for the procedure same as the first 14 days, the suspension of loperamide was administered to establish a constipation model before gavage. The water content of the feces, the time to the first black stool and the rate of small bowel advancement were measured during the experiment; the levels of peptide tyrosine-tyrosine (PYY) and motilin in serum were determined; the levels of serotonin in the colon and neurotrophin-3 in the colon were measured; the transcription of Aqp4 and c-kit in the colon was detected; and the content of short-chain fatty acids (SCFAs) in the feces was also determined. All the four strains of L. paracasei showed the role of relieving constipation, while with differences in the pathway. LC2 could alleviate the constipation through the regulation on the level of PYY, NT-3, 5-HT, Aqp4, c-kit and SCFAs, whilst other three strains showed different ways to relieve constipation. It is indicated that L. paracasei has the potential to relieve constipation, while the effects on the constipation alleviation showed significant intra-species differences.

Cite this article

YANG Shurong , ZHU Huiyue , WU Xiaobing , SUN Shanshan , SI Qian , ZHANG Qiuxiang , WANG Linlin , WANG Gang , ZHAO Jianxin , ZHANG Hao , CHEN Wei . Analysis on the different effects of Lactobacillus paracasei in relieving constipation induced by loperamide in mice[J]. Food and Fermentation Industries, 2020 , 46(2) : 25 -31 . DOI: 10.13995/j.cnki.11-1802/ts.021735

References

[1] LEPORT J. Constipation[M].S.1:Elsevier Inc,2019.
[2] CHOI C H, CHANG S K. Alteration of gut microbiota and efficacy of probiotics in functional constipation[J]. Journal of Neurogastroenterology and Motility, 2015, 21(1):4-7.
[3] MANCABELLI L, MILANI C, LUGLI G A, et al. Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses[J]. Scientific Reports, 2017, 7(1):9 879.
[4] SINGH T P, KAUR G, MALIK R K, et al. Characterization of intestinal Lactobacillus reuteri strains as potential probiotics[J]. Probiotics & Antimicrobial Proteins, 2012, 4(1):47-58.
[5] 毛丙永. 功能性低聚糖对肠道细菌的影响及机制[D]. 无锡:江南大学, 2015.
[6] 李延青, 于岩波. 功能性便秘的诊断与治疗[J]. 中国实用内科杂志, 2011, 31(2):158-160.
[7] 王琳琳. 双歧杆菌对便秘的影响及其作用机理研究 [D]. 无锡:江南大学, 2017.
[8] YANG Z H, YU H J, PAN A, et al. Cellular mechanisms underlying the laxative effect of flavonol naringenin on rat constipation model[J]. PLoS ONE, 2008, 3(10):e3 348.
[9] LINLIN W, LUJUN H, QI X, et al. Bifidobacterium adolescentis exerts strain-specific effects on constipation induced by loperamide in BALB/c mice[J]. International Journal of Molecular Sciences, 2017, 18(2):318-340.
[10] NUNOI H, MATSUURA B, UTSUNOMIYA S, et al. A relationship between motilin and growth hormone secretagogue receptors[J]. Regulatory Peptides, 2012, 176(1-3):28-35.
[11] ZHAO X, SUO H, QIAN Y, et al. Therapeutic effects of Lactobacillus casei Qian treatment in activated carbon induced constipated mice[J]. Molecular Medicine Reports, 2015, 12(2): 3 191-3 199.
[12] 闫媛, 董蕾. 消化道酪酪肽的作用和受体分布[J]. 国际消化病杂志, 2003,23(6):372-374.
[13] WANG L, GOURCAROL G, YUAN P Q, et al. Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice[J]. American Journal of Physiology Gastrointestinal & Liver Physiology, 2010, 298(1):45-56.
[14] FEDERICO A, DALLIO M, TOLONE S, et al. Gastrointestinal hormones, intestinal microbiota and metabolic homeostasis in obese patients: Effect of bariatric surgery[J]. Vivo, 2016, 30(3):321-330.
[15] 朱敏佳,杨泽俊,王菲菲,等.肠嗜铬细胞与胃肠道疾病的研究进展[J].世界华人消化杂志, 2019, 27(2):117-124.
[16] 李小兰,江敏,阮征,等.色氨酸及其代谢产物5-HT对肠道功能的作用综述[J].食品安全质量检测学报, 2014,5(7):1 997-2 002.
[17] 赵香花.新5-羟色胺4受体激动剂SHR116958促进胃肠蠕动的药理作用[D].上海:中国人民解放军海军军医大学, 2009.
[18] SPENCER N J. Constitutively active 5-HT receptors: An explanation of how 5-HT antagonists inhibit gut motility in species where 5-HT is not an enteric neurotransmitter? [J]. Frontiers in Cellular Neuroscience, 2015,9:487-492.
[19] LUND M L, EGEROD K L, ENGELSTOFT M S, et al. Enterochromaffin 5-HT cells - A major target for GLP-1 and gut microbial metabolites [J]. Molecular metabolism, 2018,11:70-83.
[20] FUKUMOTO S, TATEWAKI M, YAMADA T, et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats[J]. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 2003, 284(5):R1 269-R1 276.
[21] PARKMAN H P, RAO S S C, REYNOLDS J C, et al. Neurotrophin-3 improves functional constipation[J]. American Journal of Gastroenterology, 2003, 98(6):1 338-1 347.
[22] COULIE B, SZARRKA L A, CAMILLERI M, et al. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans[J]. Gastroenterology, 2000, 119(1):41-50.
[23] 侯晓华,陈建德. Cajal间质细胞在胃肠运动中的作用[J].中华消化杂志, 2001,21(6):360-362.
[24] 包云光,舒小莉,李小兵,等.肠神经系统递质和Cajal间质细胞在大鼠慢传输型便秘中的作用[J]. 中国当代儿科杂志, 2009, 11(6):481-485.
[25] 贾后军,童卫东,刘宝华.胃肠道Cajal间质细胞与干细胞因子/c-kit信号途径关系[J].医学研究生学报, 2010, 23(2):192-195.
[26] LI C, NIE S P, ZHU K X, et al. Effect of Lactobacillus plantarum NCU116 on loperamide-induced constipation in mice[J]. International Journal of Food Sciences and Nutrition, 2015, 66(5): 533-538.
[27] IKARASHI N, KON R, SUGIYAMA K. Aquaporins in the colon as a new therapeutic target in diarrhea and constipation[J]. International Journal of Molecular Sciences, 2016, 17(7):1 172.
[28] 李立胜,王俊平.洛哌丁胺对腹泻模型大鼠结肠水通道蛋白4表达的影响[J].胃肠病学和肝病学杂志, 2009, 18(1):57-59.
[29] 方圆之,高杰.白芍的通便作用及其对便秘小鼠结肠AQP4、VIP表达的影响[J].山东中医杂志, 2017,36(1):62-65.
[30] EDWARDS C A. Short chain fatty acids. Production and effects on gut motility[J]. Oxygen Transport to Tissue XXXIII, 1997, 427(7):155-167.
[31] 陈燕,曹郁生,刘晓华.短链脂肪酸与肠道菌群[J].江西科学, 2006, 24(1):38-40;69.
[32] HURST N R, KENDIG D M, MURTHY K S, et al. The short chain fatty acids, butyrate and propionate, have differential effects on the motility of the guinea pig colon[J]. Neurogastroenterology & Motility, 2014, 26(11):1 586-1 596.
[33] DASS N B, JOHN A K, BASSIL A K, et al. The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation[J]. Neurogastroenterology and Motility, 2007, 19(1):66-74.
Outlines

/